We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Early Gene Therapy Data Promising for Sickle Cell Anemia

News   Dec 04, 2018 | Original story from Cincinnati Children's Hospital Medical Center

 
Gene Therapy is Reversing Sickle Cell Anemia Symptoms in Preclinical Trials

Technicians work in the ISO-certified cleanroom laboratory at Cincinnati Children’s where gene-correction therapies are tested and produced for clinical trials like the one for sickle cell anemia presented by Punam Malik MD, at this year’s annual meeting of the American Society of Hematology in San Diego. Image credit: Cincinnati Children's Hospital

 
 
Advertisement
 

RELATED ARTICLES

Antiviral Against COVID-19 Reduces Damage in Mouse Lungs

News

Scientists are optimistic that a new compound, dubbed EIDD-2801, could be effective in treating the symptoms of COVID-19. The candidate drug has shown efficacy in reducing lung damage in mouse studies, and will soon progress to clinical trials in humans.

READ MORE

Genetic System Can Reduce COVID-19 Vaccine Development Timeframe

News

A multidisciplinary team at The University of Texas Medical Branch at Galveston working to combat the COVID-19 virus has a system that will unlock researchers’ ability to more quickly develop and evaluate developing vaccines, diagnose infected patients and explore whether or how the virus has evolved.

READ MORE

Clinical Trial Assesses Anti-clotting Drug for Treatment of COVID-19-related Respiratory Failure

News

A team of physician-scientists are now enrolling patients in a clinical trial to evaluate a common anti-clotting drug for the treatment of COVID-19-positive patients with acute respiratory distress syndrome.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE